Literature DB >> 21198396

Methylenetetrahydrofolate reductase polymorphisms C677T and A1298C as maternal risk factors for Down syndrome in Jordan.

May F Sadiq1, Ekhlas A Al-Refai, Amjad Al-Nasser, Mohammad Khassawneh, Qasem Al-Batayneh.   

Abstract

BACKGROUND: The activity of the methylenetetrahydrofolate reductase (MTHFR) enzyme is regulated by the two polymorphisms C677T and A1298C, which reduce enzyme activity and result in hypomethylation of chromosomes that increase the risk of nondisjunction. These polymorphisms are suggested to be risk factors for Down syndrome (DS) in some populations. AIM: The aim of this study was to test if C677T and A1298C polymorphisms are correlated to maternal risk of DS in Jordan.
METHODS: The proportions of C677T and A1298C polymorphisms were examined in 53 case mothers who delivered DS children and 29 controls. The median age of case mothers was 35 years when delivering their affected children. Polymerase chain reaction-restriction fragment length polymorphism was used for genotyping.
RESULTS: The frequency of MTHFR C677T allele in all DS mothers was 3.2-fold higher than in the controls (odds ratio [OR] = 3.12, 95% confidence interval [CI]: 1.303-7.677). Also, the proportion of 677T in the older case mothers was different from the controls, but was significantly higher in younger case mothers than in the controls (OR = 4.2, 95% CI: 1.61-10.97, p = 0.003). The proportions of 677CT and 677TT genotypes in younger cases are, respectively, 10- and 9-fold higher than in the controls. The proportions of MTHFR A1298C are significantly different among all case groups and the controls (χ(2) = 4.27, p = 0.127), but there was a significant difference between young case mothers and both older case mothers group and the controls (OR = 1.25, 95% CI: 0.405-3.85, p = 0.698).
CONCLUSIONS: There is strong association between MTHFRC677T and maternal risk of DS in Jordanian mothers younger than 35 years old and the MTHFR1298C allele has a lesser but additive risk effect in MTHFR677T/1298C compound heterozygotes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21198396     DOI: 10.1089/gtmb.2010.0057

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  8 in total

Review 1.  Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility.

Authors:  Rebecca A Jackson; Mai Linh Nguyen; Angela N Barrett; Yuan Yee Tan; Mahesh A Choolani; Ee Sin Chen
Journal:  Cell Mol Life Sci       Date:  2016-05-31       Impact factor: 9.261

2.  Polymorphism C1420T of Serine hydroxymethyltransferase gene on maternal risk for Down syndrome.

Authors:  Gustavo Henrique Marucci; Bruna Lancia Zampieri; Joice Matos Biselli; Sendi Valentin; Eny Maria Goloni Bertollo; Marcos Nogueira Eberlin; Renato Haddad; Maria Francesca Riccio; Hélio Vannucchi; Valdemir Melechco Carvalho; Erika Cristina Pavarino
Journal:  Mol Biol Rep       Date:  2011-06-18       Impact factor: 2.316

3.  Maternal MTHFR polymorphism (677 C-T) and risk of Down's syndrome child: meta-analysis.

Authors:  Amandeep Kaur; Anupam Kaur
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

Review 4.  Meta-analysis of Methylenetetrahydrofolate reductase maternal gene in Down syndrome: increased susceptibility in women carriers of the MTHFR 677T allele.

Authors:  D B Victorino; M F Godoy; E M Goloni-Bertollo; E C Pavarino
Journal:  Mol Biol Rep       Date:  2014-06-10       Impact factor: 2.316

5.  Association of methylenetetrahydrofolate reductase gene 677C > T polymorphism and Down syndrome.

Authors:  Marcelo Aguiar Costa-Lima; Márcia Rodrigues Amorim; Iêda Maria Orioli
Journal:  Mol Biol Rep       Date:  2012-11-25       Impact factor: 2.316

Review 6.  The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects.

Authors:  Fabio Coppedè
Journal:  Front Genet       Date:  2015-06-25       Impact factor: 4.599

7.  Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: a meta-analysis from 34 studies.

Authors:  Vandana Rai; Upendra Yadav; Pradeep Kumar; Sushil Kumar Yadav; Om Prakesh Mishra
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

8.  Methylenetetrahydrofolate Reductase Polymorphism and Premature Coronary Artery Disease.

Authors:  Ahmed Zaghloul; Corina Iorgoveanu; Aakash Desai; Kathir Balakumaran; Kai Chen
Journal:  Cureus       Date:  2019-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.